5.40
Endra Life Sciences Inc Stock (NDRA) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
-
|
- | - | - | - |
|
90.74%
2.7805
|
1.4578 | 3.1291 | 2.9946 | 2.9393 |
Depreciation and Amortization |
30.10%
0.0153
|
0.0219 | - | - | - |
Operating Income/Loss |
90.74%
-2.7805
|
-1.4578 | -3.1291 | -2.9946 | -2.9393 |
Income/Loss From Continuing Operations Before Tax |
90.18%
-2.7757
|
-1.4595 | -3.1008 | -2.5571 | -2.9427 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
90.18%
-2.7757
|
-1.4595 | -3.1008 | -2.5571 | -2.9427 |
|
290.18%
2.7757
|
-1.4595 | -3.1008 | -2.5571 | -2.9427 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
5.5514
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):